SynAct Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2022-12-14 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 9 179 | 79 | SEK | 725 141 | 2022-12-11 |
| 2022-12-14 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 8 988 | 82 | SEK | 737 016 | 2022-12-11 |
| 2022-12-14 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Disposal | 9 132 | 80,5 | SEK | 735 126 | 2022-12-12 |
| 2022-05-11 | SynAct Pharma AB | Marina Bozilenko | Member of the Board of Directors | Subscription | 3 175 | 63 | SEK | 200 025 | 2022-05-02 |
| 2022-05-04 | SynAct Pharma AB | Uli Hacksell | Member of the Board of Directors | Subscription | 1 588 | 63 | SEK | 100 044 | 2022-05-02 |
| 2022-05-02 | SynAct Pharma AB | Torbjörn Bjerke | Chairman of the Board of Directors | Subscription | 1 985 | 63 | SEK | 125 055 | 2022-05-01 |
| 2022-04-28 | SynAct Pharma AB | John Haurum | Member of the Board of Directors | Subscription | 1 619 | 63 | SEK | 101 997 | 2022-04-21 |
| 2022-04-27 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Subscription | 2 381 | 63 | SEK | 150 003 | 2022-04-21 |
| 2022-04-27 | SynAct Pharma AB | Thomas Boesen | Other member of the company's administrative, management or supervisory body | Exercise decrease | 26 191 | 0 | SEK | 0 | 2022-04-21 |
| 2022-04-27 | SynAct Pharma AB | BioInvest Aps | Chief Executive Officer (CEO)/Managing Directory, Member of the Board of Directors | Exercise decrease | 3 656 899 | 0 | SEK | 0 | 2022-04-21 |
| 2022-04-27 | SynAct Pharma AB | BioInvest Aps | Chief Executive Officer (CEO)/Managing Directory, Member of the Board of Directors | Subscription | 8 730 | 63 | SEK | 549 990 | 2022-04-21 |
| 2022-04-27 | SynAct Pharma AB | Patrik Renblad | Chief Financial Officer (CFO) | Subscription | 9 127 | 63 | SEK | 575 001 | 2022-04-24 |
| 2022-04-23 | SynAct Pharma AB | Terje Kalland | Member of the Board of Directors | Subscription | 3 175 | 63 | SEK | 200 025 | 2022-04-21 |
| 2022-04-23 | SynAct Pharma AB | Terje Kalland | Member of the Board of Directors | Exercise decrease | 34 925 | 0 | SEK | 0 | 2022-04-21 |
| 2022-04-22 | SynAct Pharma AB | Patrik Renblad | Chief Financial Officer (CFO) | Subscription | 400 | 63 | SEK | 25 200 | 2022-04-21 |
| 2022-04-22 | SynAct Pharma AB | Patrik Renblad | Chief Financial Officer (CFO) | Exercise decrease | 4 400 | 0 | SEK | 0 | 2022-04-21 |
| 2022-04-08 | SynAct Pharma AB | Patrik Renblad | Chief Financial Officer (CFO) | Acquisition | 3 400 | 0,35 | SEK | 1 190 | 2022-04-07 |
| 2021-09-07 | SynAct Pharma AB | Anders Dyhr Toft | Other member of the company's administrative, management or supervisory body | Acquisition | 5 648 | 104,2 | SEK | 588 521,6 | 2021-09-05 |
| 2021-09-07 | SynAct Pharma AB | Anders Dyhr Toft | Other member of the company's administrative, management or supervisory body | Acquisition | 1 300 | 102,57 | SEK | 133 341 | 2021-09-06 |
| 2021-03-01 | SynAct Pharma AB | Henrik Stage | Chief Financial Officer (CFO) | Disposal | 22 725 | 50,464 | SEK | 1 146 793,8 | 2021-02-24 |